Emerald Mutual Fund Advisers Trust’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-191,245	Closed	-$1.84M	–	222
2022 Q3	$1.84M	Buy	+191,245	New	+$1.84M	0.12%	134